Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Background Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are a class of medications initially developed to treat type 2 diabetes (T2D) and obesity
Arora Health is the entity with actual prescription authority in the Trimi program
All peptides require reconstitution with Bacteriostatic water (BAC water), sold separately
Studies find that nearly half of people who start a GLP-1 stop due to cost or side effects like nausea, vomiting, or diarrhea
Start slow: Use it daily, but you may want to begin with a lower strength and frequency
Pharmacovigilance and signal detection FAERS semaglutide disproportionality (broad): A FAERS-based disproportionality analysis of semaglutide reports through mid-2023 identified multiple unexpected adverse event signals and explicitly notes that some signals were not mentioned in the drug insert, including polycystic ovaries. The analysis highlights typical spontaneous-reporting limitations (missing age, outcome data)
US$ 20.96
US$ 20.64
US$ 28.73
US$ 20.07
